Adrian Blackburn

Adrian Blackburn is a seasoned professional in the biopharmaceutical industry, currently serving as Head of Process Development at KBI Biopharma since September 2021. Previously, Adrian held leadership positions in upstream process development at Fresenius Kabi and Merck Group, where responsibilities encompassed the optimization, validation, and tech transfer of monoclonal antibody processes. An earlier role as Principal Scientist at CMC Biologics included significant contributions to upstream development, while a tenure at Pfizer was marked by expertise in cell culture and project management for technology transfer. Academic credentials include a Ph.D. in Organic Chemistry from the University of Bristol and a B.Sc. (Hons.) in Chemistry from the University of Aberdeen.